Home
About
Our Work
Success Stories
Insights
Contact
OUR WORK
Explore recent placements
Unmatched talent to bring you an unmatched advantage.
All Posts
Board
CEO
CFO
Comms/IR
COO
CDO/CTO
CSO
CMO
CBO
CPO
CLO
CRO
CDO/CTO
Occam Places Chief Development Officer of Groundbreaking Longevity Player, Loyal
5.1.24
CEO
Occam Recruits Brent Warner as CEO for Protego Biopharma
4.16.24
Board
Occam Enhances CytomX's Board with Experienced Physician Executive
3.21.24
CSO
Occam Places CSO of ADC Biotech MBrace Therapeutics
3.6.24
CDO/CTO
Occam Places Adrian Schreyer as CTO of Anagenex
3.4.24
CSO
Occam Recruits Translational Leader for Gene Editing Leader Mammoth
2.27.24
CSO
Occam Recruits CSO for Public Gene Therapy Company, Adverum
2.2.24
Board
Occam Places Biotech Leader David Southwell as Chairman of Revolo Biotherapeutics
1.25.24
CBO
Occam Recruits CBO for Parisian Generative AI Drug Discovery Platform Company, Iktos
1.18.24
CEO
Occam Recruits Sanjeev Luther as President and CEO of Eterna Therapeutics
12.22.23
Board
Occam's AI Practice Expands with the Recruitment of Dr. Rajiv Patni as Strategic Clinical Advisor to BioXcel Therapeutics
12.15.23
CSO
Occam’s UK Biotech Practice Accelerates with Placement of CSO at Nucleome
11.13.23
CEO
Occam Recruits CEO of Prominent Rare Disease Research Foundation
11.9.23
CMO
Occam Continues to Serve the Gene Therapy/Gene Editing Space, Recruiting Wes Miller as CMO of Epic Bio
10.24.23
CDO/CTO
Occam Places Senior DeepMind Leader as VP of AI/ML at GSK
10.16.23
CSO
Occam Places Manju Ramarao as CSO of Atomic AI
10.12.23
CSO
Occam Places Nick Pullen as CSO of ARTBIO
10.5.23
CFO
Key Financial Executive Placement Expands Global Tech Practice
9.28.23
CLO
Occam Places General Counsel for Public Biopharma KalVista Pharmaceuticals
9.21.23
CFO
Occam Recruits Michelle Robertson as CFO of Geron Corporation
9.15.23
CLO
Occam Places Chief Legal Officer at Public Oncology Biotech
8.12.23
CEO
Occam Places Bryan Stuart as CEO of Atavistik
7.20.23
CSO
Occam Places Kimberly Scearce-Levie as Chief Development Officer of Cajal Neuroscience
7.17.23
CRO
Occam's Tech Practice Places CRO at Engageli, a Collaborative SW Developer
7.10.23
Board
Occam Places Mark Strobeck on the Board of Windtree
7.4.23
CEO
Occam Places CEO for RadioPharm Start-Up
6.27.23
CBO
Occam’s UK Practice Expands, Placing Swati Chatterjee as SVP Sales & Business Development of Chemify
6.15.23
CSO
Occam Recruits David Moller as Chief Scientific Officer of Variant Bio
6.6.23
CFO
Occam Places Brian Piekos as CFO of Elicio Therapeutics
6.2.23
CMO
Occam Places R&D Leader David Mauro as CMO at Recursion
5.16.23
COO
CDO/CTO
Occam’s Global Tech Practice Continues to Expand, Placing Daniel Delubac as COO & CTO at Chemify
5.3.23
Board
Occam Places Andrew Allen as Board Chair of Peptone
4.24.23
Board
Occam Places Ann Taylor as Board Member at Comanche Biopharma
4.12.23
CEO
Occam Places Dan Kemp as CEO of Shinobi Therapeutics
4.3.23
Board
Occam Places Alex Dickinson as Board Member of Gencove
3.21.23
CFO
Occam Places Kevin Coveney as CFO of Enveric Biosciences
3.21.23
CMO
Occam Places Allison August as CMO at Comanche Bio
3.7.23
CSO
Occam Places Steve Colletti as CSO of Korro Bio
2.28.23
CSO
CDO/CTO
Occam Places Edith Hessel as CSO and Lindsay Edwards as CTO at Relation Therapeutics
2.22.23
COO
Occam Places Carolyn Haley as COO at F-Prime Capital
2.13.23
Load More
No Results Found!
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.